You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
A miscarriage of justice in the RATPAC trial?
  1. Robert Wardrop
  1. Correspondence to Mr Robert Wardrop, POCT, PathWest Laboratory Medicine WA, QEII Medical Centre, Nedlands, Western Australia 6009, Australia; robert.wardrop{at}health.wa.gov.au

http://dx.doi.org/10.1136/heartjnl-2011-301342

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    To the Editor Having read the three papers published on the Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial,1–3 I have come to the conclusion that there has been a major miscarriage of justice. That miscarriage of justice relates to diagnostic equipment used in the standard treatment protocols for the hospitals involved in the RATPAC trial (Beckman Access, Centaur CP and Roche E170). The point-of-care testing (POCT) was not convincingly vindicated in this trial but the other equipment and methods were deemed by association of the data to be inadequate. A cursory examination of …

    View Full Text

    Footnotes

    • Linked article 301343.

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles

    • PostScript
      The Authors' reply
      Steve W Goodacre Paul Collinson Alasdair Gray on behalf of the RATPAC Research Team
      Heart 2011; 98 170-171 Published Online First: 29 Nov 2011. doi: 10.1136/heartjnl-2011-301343